WePeptideRx Tirzepatide Review: Dose Prices and Refunds
Researched & written by Alan PierceClinical Pharmacology WriterUpdated
On this page
Dose and supply-period menus differ from the overview prices; obtain the selected total.
Standout details
- Publishes dose-specific thirty- and ninety-day menus
- Advertises consultation, medication, supplies and shipping in the package
Things to consider
- Menu and overview amounts conflict; no universal monthly or refill price
- Payment precedes clinical review; dispensed and shipped medication is final
WePeptideRx's current named Compounded Tirzepatide / B12 product page shows a thirty-day starter option at $159 and other thirty-day dose tiers at $199, $249, $269, $319 and $349. The old single $249 monthly description does not represent every dose. Its public page also contains conflicting overview prices, so a selected prescription quote remains essential.3
Distinguish dose choices from a confirmed prescription
The thirty-day card labels its list regular pricing after first order and maps those amounts to six dose tiers. Its ninety-day programs show $489, $509, $529, $549 or $559 for different starting ranges. Those are program totals, not monthly installments; a ninety-day period is not necessarily three calendar months. These are advertised menu choices, not dosing recommendations or a guarantee that a clinician will approve the selected range.3
Elsewhere on the same page, an overview still says $199–$389 for thirty days and $529–$599 for ninety days. Do not combine these with the dose cards into an assumed first-order or renewal schedule. Confirm the amount charged now, the actual supply and later refill price.3
The product page advertises consultation, medication, syringes, alcohol pads, dosing instructions and priority shipping in its package. It offers an optional $10 review of existing labs; that is not the cost of obtaining a new lab panel. It describes B12 and glycine in monthly doses and B12 without glycine in the ninety-day program, while allowing clinician customization. Confirm the precise prescribed ingredients and concentration.3
| Topic | What to know |
|---|---|
| Thirty-day dose cards | $159 starter; other tiers $199 to $349 |
| Ninety-day program cards | $489 to $559 totals across starting ranges |
| Conflicting overview | $199–$389 for 30 days; $529–$599 for 90 days |
| Lab review | Optional $10 for reviewing existing results |
Payment precedes provider approval
The refund policy says checkout charges occur before clinical review and reserve the consultation. If the provider finds an item inappropriate, it promises a full refund of that item to the original card, normally issued within five business days after the decision, with bank posting potentially taking longer. Paying does not guarantee a prescription.4,5
Medication that has been dispensed and shipped is non-refundable under the policy. Cancellation or pausing must be requested before the next billing cycle by contacting support. Report damaged, incorrect or quality-related deliveries within 48 hours; the policy describes coordination with the pharmacy, potentially including a replacement. It also promises a replacement when a lost package cannot be recovered. Confirm how these rules apply to a prepaid ninety-day program and any remaining supply.4
| Topic | What to know |
|---|---|
| Payment | Collected at checkout before provider review |
| Medical nonapproval | Full item refund to original card; normally issued within five business days |
| Medication and renewal | Dispensed/shipped medication final; cancel before next cycle |
| Delivery problems | Report damage, wrong item or quality concern within 48 hours |
Public identities do not establish assignment
The terms name PureRx Biotech INC, doing business as WePeptideRx, and specify Florida law and arbitration in Boca Raton. Its clinical disclosure names Hridyesh Nat, MD as medical director and describes a third-party telemedicine network. This corrects the old assertion that no director or legal entity is disclosed; it does not independently verify credentials or identify your treating clinician.5,6
The state page lists forty-eight available states and marks Alabama and Mississippi not yet available, while broader pages discuss all-state director licensure. Professional licensure and program availability are separate. Confirm your location, treatment eligibility and actual preparing and dispensing pharmacies. Confirm the currently available plan, accepted quote and governing renewal agreement before paying; a public menu does not establish individual treatment availability.7 Compounded drugs are not FDA-approved; brand-drug trial results do not validate this particular preparation.1,2,3
Further reading
whether compounded tirzepatide is still legal in 2026, Zepbound side effects, the gallbladder risk, thyroid cancer warning, tirzepatide evidence guide, Vitara RX, VyraRX, best tirzepatide providers.
Frequently asked questions
Is WePeptideRx tirzepatide always $249 monthly?
No. The thirty-day dose cards show $159 for the starter tier and $199 through $349 for other tiers. Other overview figures differ. Obtain the prescribed dose, supply and selected total before paying.
Am I charged before the provider decides?
The refund policy says yes. It promises a full item refund to the original card when the provider declines that treatment, normally issued within five business days after the decision, with additional bank posting time possible.
Can I cancel or return medication?
Request cancellation or pausing before the next billing cycle. Dispensed and shipped medications are non-refundable. Report damaged, incorrect or quality-related deliveries within 48 hours and confirm the policy for a prepaid ninety-day program.
References(8)
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
- Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
- WePeptideRx (2026). Current named compounded tirzepatide dose and supply menu. WePeptideRx.
- WePeptideRx (2026). Payment, nonapproval refund, cancellation and delivery policy. WePeptideRx.
- WePeptideRx (2026). Legal entity, service eligibility and payment terms. WePeptideRx.
- WePeptideRx (2026). Medical director and clinical network disclosure. WePeptideRx.
- WePeptideRx (2026). Published state availability. WePeptideRx.
- WePeptideRx (2026). Current homepage-linked application product configuration. WePeptideRx.
About the author
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Browse provider reviewsVitara RX Tirzepatide Review: Pricing and Refund Stages
Vitara RX review: the $149 tirzepatide card, conflicting program headline, named pharmacy and clinical network, plus cancellation and shipping questions.
ReadVyraRX Tirzepatide Review: Fees, States and Cancellation
VyraRX review: $329 starting price, provider messaging, three excluded states, and separate subscription cancellation and medication refund rules.
ReadIs Compounded Tirzepatide Still Legal in 2026?
Tirzepatide's shortage ended in 2024 and FDA's compounding grace period closed in early 2025. Here's the precise legal status of compounded tirzepatide in 2026.
ReadZepbound Side Effects: Full Breakdown by Frequency
Compare common Zepbound side effects by dose, see trial frequencies and learn which warning signs need prompt medical attention.
ReadTirzepatide and Gallbladder Problems
How often tirzepatide causes gallstones and cholecystitis, why rapid weight loss is part of it, and the red-flag symptoms that need urgent care.
ReadTirzepatide Thyroid Cancer Warning Explained
What tirzepatide's boxed thyroid C-cell tumor warning actually means: verbatim FDA label text, the rat data behind it, and what human evidence shows.
Read